CAM
Cypress Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-1,650
| Closed | -$458K | – | 138 |
|
2019
Q3 | $458K | Sell |
1,650
-210
| -11% | -$58.3K | 0.16% | 107 |
|
2019
Q2 | $582K | Sell |
1,860
-5
| -0.3% | -$1.57K | 0.2% | 101 |
|
2019
Q1 | $766K | Sell |
1,865
-108
| -5% | -$44.4K | 0.26% | 97 |
|
2018
Q4 | $737K | Sell |
1,973
-575
| -23% | -$215K | 0.28% | 91 |
|
2018
Q3 | $1.03M | Sell |
2,548
-357
| -12% | -$144K | 0.3% | 89 |
|
2018
Q2 | $1M | Sell |
2,905
-435
| -13% | -$150K | 0.3% | 90 |
|
2018
Q1 | $1.15M | Sell |
3,340
-3,791
| -53% | -$1.31M | 0.34% | 86 |
|
2017
Q4 | $2.68M | Sell |
7,131
-1,446
| -17% | -$544K | 0.58% | 57 |
|
2017
Q3 | $3.84M | Sell |
8,577
-1,343
| -14% | -$600K | 0.83% | 41 |
|
2017
Q2 | $4.87M | Sell |
9,920
-2,052
| -17% | -$1.01M | 1% | 34 |
|
2017
Q1 | $4.64M | Sell |
11,972
-722
| -6% | -$280K | 0.89% | 36 |
|
2016
Q4 | $4.66M | Buy |
12,694
+89
| +0.7% | +$32.7K | 0.89% | 36 |
|
2016
Q3 | $5.07M | Sell |
12,605
-350
| -3% | -$141K | 1.01% | 31 |
|
2016
Q2 | $4.52M | Sell |
12,955
-1,125
| -8% | -$393K | 0.9% | 32 |
|
2016
Q1 | $5.08M | Sell |
14,080
-65
| -0.5% | -$23.4K | 1.03% | 32 |
|
2015
Q4 | $7.68M | Sell |
14,145
-400
| -3% | -$217K | 1.54% | 18 |
|
2015
Q3 | $6.77M | Sell |
14,545
-50
| -0.3% | -$23.3K | 1.42% | 20 |
|
2015
Q2 | $7.45M | Hold |
14,595
| – | – | 1.4% | 22 |
|
2015
Q1 | $6.59M | Buy |
14,595
+2,830
| +24% | +$1.28M | 1.23% | 24 |
|
2014
Q4 | $4.83M | Buy |
11,765
+225
| +2% | +$92.3K | 0.89% | 36 |
|
2014
Q3 | $4.16M | Sell |
11,540
-1,405
| -11% | -$506K | 0.75% | 44 |
|
2014
Q2 | $3.66M | Sell |
12,945
-1,885
| -13% | -$533K | 0.63% | 54 |
|
2014
Q1 | $4.45M | Sell |
14,830
-1,655
| -10% | -$497K | 0.81% | 41 |
|
2013
Q4 | $4.54M | Sell |
16,485
-400
| -2% | -$110K | 0.79% | 41 |
|
2013
Q3 | $5.28M | Sell |
16,885
-35
| -0.2% | -$11K | 0.98% | 33 |
|
2013
Q2 | $3.81M | Buy |
+16,920
| New | +$3.81M | 0.71% | 44 |
|